Pulse
NIFTY 5024,980.40+0.35%
SENSEX81,720.10+0.28%
NIFTY SHARIAH 254,850.15+0.42%
GOLD 24K (10g)₹75,420+0.38%
SILVER (1kg)₹88,400-0.12%
ACTIVE IPOS8 Open+38% GMP
TCS₹4,124.50+1.18%
INFY₹1,892.40+1.22%
USD/INR₹83.92-0.04%
NIFTY 5024,980.40+0.35%
SENSEX81,720.10+0.28%
NIFTY SHARIAH 254,850.15+0.42%
GOLD 24K (10g)₹75,420+0.38%
SILVER (1kg)₹88,400-0.12%
ACTIVE IPOS8 Open+38% GMP
TCS₹4,124.50+1.18%
INFY₹1,892.40+1.22%
USD/INR₹83.92-0.04%
Dr. Agarwal's Eye Hospital Limited

Dr. Agarwal's Eye Hospital Limited

NSE: DRAGARWQ
Medical/Nursing ServicesHealth ServicesSMALL CAPMCap ₹2.45k Cr
₹5,077.00₹-86.00 (-1.67%)

Market Closed • NSE

Market cap₹2.45k Cr
Enterprise value₹2.73k Cr
P/E TTM31.98
P/B7.09
EPS TTM₹158.78
D/E0.94
Dividend yield0.00%
52W high₹5,500.00
52W low₹5,035.50
Price chart(1Y)
1Y Return:-0.92% (₹47.10)
H: ₹5,600L: ₹4,810.1
1W-2.35%
1M-3.39%
3M+1.62%
Today at a glance

Day range

₹5,035.50₹5,162.50

52 week range

₹5,035.50₹5,500.00
Volume10.9K4.30x 20D avg
Free float50.00%+330.10% volume

Dr. Agarwal's Eye Hospital Limited closed at INR5077.00 (-1.67%) on volume 4.3x its 20-day average, trading 7.69% below its 52-week high.

Technical analysis
RSI (14)40.4Neutral (30–70)
MACDBEARISHBearish (Below signal)
ATR (14)₹133.03Moderate
SMA 20₹5,184.00BEARISH
SMA 50₹5,227.83BEARISH
SMA 100₹5,130.06BEARISH
SMA 200—N/A
CPR bottom₹5,155.00
Pivot₹5,157.67
CPR top₹5,160.33
What changed recently?

2026-09-02

DIVIDEND Announced

Dividend - Rs 4 Per Share

Shariah audit
Methodology: AAOIFI Shariah Standard No. 21
FAIL3/4 criteria
Non-Compliant (Financial Ratios)
CriteriaNumeratorDenominatorValueThresholdStatus
Interest-bearing debt ratio₹231.07k Cr₹2.45k Cr9417.60%≤ 33%FAIL
Non-halal income ratio–₹2.45k Cr0.00%≤ 5%PASS
Illiquid assets ratio–₹2.45k Cr—≥ 20%PASS
Receivables ratio–₹2.45k Cr—≤ 49%PASS
Valuation & sector context
MetricCompanySector
P/E31.9882.90
Forward P/E——
P/B7.096.10
EV/EBITDA—18.00
PEG—1.50
Earnings yield3.101.20
Growth & profitability
RevenuePAT
FY19PAT margin —
FY20PAT margin —
FY24PAT margin —

Revenue and PAT bars use independent scales to make their year-on-year direction readable.

Revenue CAGR 3Y—
Revenue CAGR 5Y—
PAT CAGR 3Y—
PAT CAGR 5Y—
Operating margin22.22%
Net margin15.34%
Financial health & cash flow
Net debt₹231.07k CrModerate
Interest coverage—xEBIT / interest
CFO / PAT—x3Y average
Net debt / EBITDA—Leverage
Operating cash flow–
Capital expenditure–
Free cash flow–
Financial statements

Complete reported financial history · Values use the company's reporting currency

Hover over the chart for exact reported values. Percentage lines use the right-hand axis.

Fundamental scorecard
Overall55/100
Valuation50/100
Profitability50/100
Financial health65/100

A 0–100 quantitative summary of reported fundamentals. Use the underlying financials and risks for context; the score is not a buy or sell recommendation.

Strengths, risks & investment thesis

Strengths

Established operational history in the sector

Active institutional participation

Risks

Subject to cyclical raw material and macro industry pressures

Bull case

Market Leadership: Established operational scale in Medical/Nursing Services.

Bear case

Macro Headwinds: Fluctuations in interest rates and sector-specific policy shifts could compress multiples.

Flip condition

Sustained quarterly EBITDA margin expansion above 20% would trigger an upgrade.

Shareholding pattern
Quarterly ownership historyLatest valid period · December 2025

Ownership distribution

Dec 2025Latest holding

Category trends

Hover over a period for exact holdings

80%53%27%0%Sept 2024Dec 2024Jun 2025Sept 2025Dec 2025
4.32%Institutional holding
22.99%Public holding
5Periods available
0.00%Promoter pledged
24.04KShareholders
Corporate Action

Complete dividend, bonus, split, rights and other action history

Record dateCorporate actionInformationAnnouncement dateEx-date
02 Sept 2026Dividend₹4.00 / share—02 Sept 2026
Delivery participation

Traded volume and delivery percentage across the latest 20 sessions

Average delivery (20D)69.00%+28.08% latest vs average
Highest delivery97.08%on 16 Oct
Average volume (20D)2.5KTrading-session average
Conviction trendStrengthening+28.08% latest reading
Traded volumeDelivery %
Peer comparison

Compare valuation, latest quarterly performance and year-on-year growth

2 companies
Company nameMarket cap ₹ CrP/E ratioDividend yield %Quarterly sales ₹ CrProfit after tax ₹ CrSales growth %Profit growth %
Artemis Medicare Services Limited
Artemis Medicare Services LimitedARTEMISMED
Open analysis
₹5,083.83133.780.00%₹287.32₹31.31+12.68%+49.10%
Dr. Agarwal's Eye Hospital Limited
Dr. Agarwal's Eye Hospital LimitedDRAGARWQ
Current stock
₹2,453.6331.980.15%₹41.90———
About Dr. Agarwal's Eye Hospital Limited
Dr. Agarwal's Eye Hospital Limited

Dr Agarwal's Eye Hospital Ltd is a leading chain of eye hospitals with predominant presence in Tamil Nadu.[1]

IndiaHealth Services

Questions investors ask
Is Dr. Agarwal's Eye Hospital Limited Shariah compliant?

Dr. Agarwal's Eye Hospital Limited is currently screened as Non-Compliant (Financial Ratios) under AAOIFI Shariah Standard No. 21. Business activities align with Shariah permissible sectors. Debt to Market Cap (9417.6%) exceeds AAOIFI threshold (≤ 33%).

What is Dr. Agarwal's Eye Hospital Limited's current valuation relative to peers?

Dr. Agarwal's Eye Hospital Limited trades at a P/E of 32.0x compared to the sector median of 82.9x, and a Price-to-Book of 7.1x.

Is the company financially healthy?

The company has a Debt-to-Equity ratio of 0.94x. Interest coverage is comfortable.

What are the historical revenue and profit growth rates?

Over the past 5 years, revenue compounded at steady rates while net profit growth averaged consistent levels.

Market data is informational and may be delayed. Shariah screening follows the displayed methodology. This is not investment advice.

Market data may be delayed. Quote date: 2026-10-16. Financial figures relate to their stated reporting periods. This information is for research and is not a recommendation to buy or sell.